| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Former 10% Owner
14 companies
Wellington Biomedical Innovation Master Investors (cayman) I L.P. last filed a Form 4 in September 2024, as 10% Owner at GBIO. The filings on record cover 14 companies.
At the last filing, the largest reported position was 959,211 shares of KYMR.
Wellington Biomedical Innovation Master Investors (cayman) I L.P. has 14 Form 4 filings on record from February 2020 to September 2024, across 14 companies: 10% Owner at Zenas BioPharma (ZBIO), 2024; 10% Owner at Artiva Biotherapeutics (ARTV), 2024; 10% Owner at Boundless Bio (BOLD), 2024, and 11 more.
The 21 reported transactions were 19 conversions, 1 other transaction and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $20.9M and no sales.
The only open-market purchase was 1,100,000 shares of GBIO at an average $19.00 on June 16, 2020, about $20.9M.
Shares as reported in the last Form 4 for each company; the most recent is from September 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2020 | GBIO Generation Bio Co. | 10% Owner | Buy | 1,100,000 | $19.00 | $20,900,000.00 | +108.6% |